Effects of Talampanel on Patients With Advanced Parkinson's Disease

Clinical trial NCT00036296 · COMPLETED

Trial details

NCT number: NCT00036296
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Dyskinesias Parkinson Disease Movement Disorders

Start date: 2006-12-01
Primary completion: 2007-02-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.